Synthetic biology – pathways to commercialisation
Synthetic biology is transforming the ability to manufacture increasingly needed bio-based products in response to rising market demand. By applying engineering principles to the convolution of recent advances in genomic engineering techniques, information technology and automation, synthetic biolog...
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2019-02-01
|
| Series: | Engineering Biology |
| Subjects: | |
| Online Access: | https://digital-library.theiet.org/content/journals/10.1049/enb.2018.5009 |
| _version_ | 1818570201037275136 |
|---|---|
| author | Lionel J. Clarke |
| author_facet | Lionel J. Clarke |
| author_sort | Lionel J. Clarke |
| collection | DOAJ |
| description | Synthetic biology is transforming the ability to manufacture increasingly needed bio-based products in response to rising market demand. By applying engineering principles to the convolution of recent advances in genomic engineering techniques, information technology and automation, synthetic biology is facilitating the replacement of time-consuming ‘discover and grow’ approaches by more precise and affordable ‘biodesign and biomanufacture’ processes. Meantime, societal awareness of specific health, well-being, and environmental issues is increasing ‘market pull’ that will shape future pathways to commercialisation. Market interests will not only shape targets for product function and cost but also increasingly question their provenance. Sustainability concerns are already driving demand to replace petrochemical-derived by bio-derived products, but many established industries wishing to transition may lack familiarity with bio-manufacturing processes and with the wider issues associated with large-scale bio-feedstock supply chains. Meantime, commercialisation of synthetic biology today is being advanced mostly via start-ups and SMEs. Combining the knowledge and skills required to respond to market interests, as the scale of operations and complexity of issues expands, is likely to stimulate an increasing diversity of collaborative approaches. |
| first_indexed | 2024-12-14T06:57:33Z |
| format | Article |
| id | doaj.art-50ab1b20c7fa44fc81ad457610b88b36 |
| institution | Directory Open Access Journal |
| issn | 2398-6182 |
| language | English |
| last_indexed | 2024-12-14T06:57:33Z |
| publishDate | 2019-02-01 |
| publisher | Wiley |
| record_format | Article |
| series | Engineering Biology |
| spelling | doaj.art-50ab1b20c7fa44fc81ad457610b88b362022-12-21T23:12:35ZengWileyEngineering Biology2398-61822019-02-0110.1049/enb.2018.5009ENB.2018.5009Synthetic biology – pathways to commercialisationLionel J. Clarke0Imperial CollegeSynthetic biology is transforming the ability to manufacture increasingly needed bio-based products in response to rising market demand. By applying engineering principles to the convolution of recent advances in genomic engineering techniques, information technology and automation, synthetic biology is facilitating the replacement of time-consuming ‘discover and grow’ approaches by more precise and affordable ‘biodesign and biomanufacture’ processes. Meantime, societal awareness of specific health, well-being, and environmental issues is increasing ‘market pull’ that will shape future pathways to commercialisation. Market interests will not only shape targets for product function and cost but also increasingly question their provenance. Sustainability concerns are already driving demand to replace petrochemical-derived by bio-derived products, but many established industries wishing to transition may lack familiarity with bio-manufacturing processes and with the wider issues associated with large-scale bio-feedstock supply chains. Meantime, commercialisation of synthetic biology today is being advanced mostly via start-ups and SMEs. Combining the knowledge and skills required to respond to market interests, as the scale of operations and complexity of issues expands, is likely to stimulate an increasing diversity of collaborative approaches.https://digital-library.theiet.org/content/journals/10.1049/enb.2018.5009genomicsbiofuelmanufacturing processesbioenergy conversionbiotechnologysupply chainscellular biophysicssustainable developmentpetrochemicalsindustrial economicssynthetic biology – pathwayscommercialisationauthorsbio-based productsrising market demandengineering principlesconvolutiongenomic engineering techniquestime-consumingaffordable biodesignbiomanufacture processessocietal awarenessspecific healthenvironmental issuesmarket pullfuture pathwaysmarket interestsproduct functioncostsustainability concernspetrochemical-derivedbio-derived productsbio-manufacturing processeswider issueslarge-scale bio-feedstock supply chainssynthetic biology todayissues expandsincreasing diversity |
| spellingShingle | Lionel J. Clarke Synthetic biology – pathways to commercialisation Engineering Biology genomics biofuel manufacturing processes bioenergy conversion biotechnology supply chains cellular biophysics sustainable development petrochemicals industrial economics synthetic biology – pathways commercialisation authors bio-based products rising market demand engineering principles convolution genomic engineering techniques time-consuming affordable biodesign biomanufacture processes societal awareness specific health environmental issues market pull future pathways market interests product function cost sustainability concerns petrochemical-derived bio-derived products bio-manufacturing processes wider issues large-scale bio-feedstock supply chains synthetic biology today issues expands increasing diversity |
| title | Synthetic biology – pathways to commercialisation |
| title_full | Synthetic biology – pathways to commercialisation |
| title_fullStr | Synthetic biology – pathways to commercialisation |
| title_full_unstemmed | Synthetic biology – pathways to commercialisation |
| title_short | Synthetic biology – pathways to commercialisation |
| title_sort | synthetic biology pathways to commercialisation |
| topic | genomics biofuel manufacturing processes bioenergy conversion biotechnology supply chains cellular biophysics sustainable development petrochemicals industrial economics synthetic biology – pathways commercialisation authors bio-based products rising market demand engineering principles convolution genomic engineering techniques time-consuming affordable biodesign biomanufacture processes societal awareness specific health environmental issues market pull future pathways market interests product function cost sustainability concerns petrochemical-derived bio-derived products bio-manufacturing processes wider issues large-scale bio-feedstock supply chains synthetic biology today issues expands increasing diversity |
| url | https://digital-library.theiet.org/content/journals/10.1049/enb.2018.5009 |
| work_keys_str_mv | AT lioneljclarke syntheticbiologypathwaystocommercialisation |